LLY Financial Facts
Research and development: 1.24BCost of sales, operating expenses, and other-net: 4.22B
See Full Income Statement
Accrued retirement benefit: 2.08B
Total other assets: 15.95B
See Full Balance Sheet
Eli Lilly (LLY) Earnings
|
Expand Research on LLY
| Next EPS Date | 4/30/24 | EPS Growth Rate | +53.1% |
|---|---|---|---|
| Average EPS % Beat Rate | +40.1% | Revenue Growth Rate | +28.4% |
| Average % Move 1-Wk after EPS | +12.3% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
4/30/24  |
Q124 | N/A | $2.48 | N/A | N/A | $8.94B | = | N/A | N/A | ||
| 8/4/22 | Q222 | $1.25 | $1.71 | -$0.46 | $6.49B | $6.85B | = |  | | Details | |
| 4/27/21 |  |
Q121 | $1.87 | $2.14 | -$0.27 | $6.81B | $7.02B | = | | | Details |
| 10/27/20 | |
Q320 | $1.54 | $1.71 | -$0.17 | $5.74B | $5.91B | = | | | Details |
| 4/27/23 | Q123 | $1.62 | $1.69 | -$0.07 | $6.96B | $6.84B |  |
| | Details | |
| 10/25/16 |
|
Q316 | $0.88 | $0.95 | -$0.07 | $5.19B | $5.29B | N/A | | | Details |
| 8/3/21 | |
Q221 | $1.87 | $1.92 | -$0.05 | $6.74B | $6.65B | = | | | Details |
| 10/24/12 |
|
Q312 | $0.79 | $0.82 | -$0.03 | $5.44B | $5.61B |  |
| | Details |
